These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29894077)

  • 21. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors.
    Jones MW; Onisko A; Dabbs DJ; Elishaev E; Chiosea S; Bhargava R
    Int J Gynecol Cancer; 2013 Feb; 23(2):380-4. PubMed ID: 23318908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ER-positive endocervical adenocarcinoma mimicking endometrioid adenocarcinoma in morphology and immunohistochemical profile: A case report of application of HPV RNAscope detection.
    Chen R; Qin P; Luo Q; Yang W; Tan X; Cai T; Jiang Q; Chen H
    Medicine (Baltimore); 2021 Apr; 100(13):e24927. PubMed ID: 33787580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
    Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
    Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
    McCluggage WG; Sumathi VP; McBride HA; Patterson A
    Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined expression of p161NK4a and p27Kip1, but not p21WAF1, differentiates endocervical from endometrial adenocarcinoma.
    Abu Backer FM; Mustapha NR; Othman NH
    Anal Quant Cytol Histol; 2011 Oct; 33(5):283-8. PubMed ID: 22611756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.
    Alkushi A; Irving J; Hsu F; Dupuis B; Liu CL; Rijn M; Gilks CB
    Virchows Arch; 2003 Mar; 442(3):271-7. PubMed ID: 12647218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
    Liou S; Nilforoushan N; Kang Y; Moatamed NA
    Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
    Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
    Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.
    Elishaev E; Gilks CB; Miller D; Srodon M; Kurman RJ; Ronnett BM
    Am J Surg Pathol; 2005 Mar; 29(3):281-94. PubMed ID: 15725796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
    Han CP; Kok LF; Lee MY; Wu TS; Ruan A; Cheng YW; Wang PH; Koo CL; Tyan YS
    Arch Gynecol Obstet; 2010 Feb; 281(2):317-23. PubMed ID: 19444461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma.
    Khoury T; Tan D; Wang J; Intengan M; Yang J; Alrawi S; Yan P; Byrd JC
    BMC Clin Pathol; 2006 Jan; 6():1. PubMed ID: 16409624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Kok LF; Lee MY; Tyan YS; Wu TS; Cheng YW; Kung MF; Wang PH; Han CP
    Arch Gynecol Obstet; 2010 Feb; 281(2):293-300. PubMed ID: 19418062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study.
    Castrillon DH; Lee KR; Nucci MR
    Int J Gynecol Pathol; 2002 Jan; 21(1):4-10. PubMed ID: 11781516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Panel of Villin, Pro-Ex-C, Estrogen Receptor and Progesterone Receptor Expressions Could Help in Differentiation Between Endocervical and Endometrioid Adenocarcinoma.
    Elfeky M; Harb O; Gertallah L
    Turk Patoloji Derg; 2017; 1(1):29-40. PubMed ID: 28832070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions.
    Danialan R; Assaad M; Burghardt J; Newcomb P; Cartun RW; Mandavilli S
    Gynecol Oncol; 2013 Aug; 130(2):383-8. PubMed ID: 23618832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P16 as a molecular biomarker of cervical adenocarcinoma.
    Schorge JO; Lea JS; Elias KJ; Rajanbabu R; Coleman RL; Miller DS; Ashfaq R
    Am J Obstet Gynecol; 2004 Mar; 190(3):668-73. PubMed ID: 15041997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
    Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
    Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.